{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:27:28Z","timestamp":1790638048599,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.celrep.2021.109167","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T11:37:22Z","timestamp":1621942642000},"page":"109167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5347-4301","authenticated-orcid":false,"given":"Evan D.","family":"Rossignol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Dugast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacheming","family":"Compere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-3083","authenticated-orcid":false,"given":"Christopher A.","family":"Cottrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Copps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3400-7203","authenticated-orcid":false,"given":"Shu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3231-7726","authenticated-orcid":false,"given":"Deniz","family":"Cizmeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-3769","authenticated-orcid":false,"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Julg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2021.109167_bib1","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1128\/JVI.02194-14","article-title":"Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection","volume":"88","author":"Acharya","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib2","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2021.109167_bib3","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1128\/JVI.03403-12","article-title":"Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for Fc\u03b3R2a and Fc\u03b3R2b","volume":"87","author":"Ackerman","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib4","doi-asserted-by":"crossref","first-page":"e1005315","DOI":"10.1371\/journal.ppat.1005315","article-title":"Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control","volume":"12","author":"Ackerman","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.109167_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.chom.2019.03.002","article-title":"An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity","volume":"25","author":"Alsahafi","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2021.109167_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00293-19","article-title":"Antibody-Induced Internalization of HIV-1 Env Proteins Limits Surface Expression of the Closed Conformation of Env","volume":"93","author":"Anand","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib7","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1073\/pnas.1321507111","article-title":"Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity","volume":"111","author":"Arias","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109167_bib8","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.109167_bib9","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1128\/JVI.01023-12","article-title":"Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family","volume":"86","author":"Bonsignori","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-018-0600-6","article-title":"Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys","volume":"563","author":"Borducchi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109167_bib11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2014.08.023","article-title":"Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in\u00a0vivo activity","volume":"158","author":"Bournazos","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109167_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jim.2018.01.013","article-title":"Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1\/SIV","volume":"455","author":"Brown","year":"2018","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.celrep.2021.109167_bib13","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1038\/ncomms10844","article-title":"Elimination of HIV-1-infected cells by broadly neutralizing antibodies","volume":"7","author":"Bruel","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.109167_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.02440-16","article-title":"Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies","volume":"91","author":"Bruel","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib15","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41467-018-04220-w","article-title":"Single molecule fate of HIV-1 envelope reveals late-stage viral lattice incorporation","volume":"9","author":"Buttler","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.109167_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jmb.2011.04.042","article-title":"HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation","volume":"410","author":"Checkley","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.celrep.2021.109167_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41467-017-00515-6","article-title":"Envelope glycoprotein mobility on HIV-1 particles depends on the virus maturation state","volume":"8","author":"Chojnacki","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.109167_bib18","doi-asserted-by":"crossref","first-page":"228ra38","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2021.109167_bib19","article-title":"Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth","author":"Cizmeci","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2021.109167_bib20","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.1601473","article-title":"Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms","volume":"198","author":"Cleary","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib21","doi-asserted-by":"crossref","first-page":"e1006786","DOI":"10.1371\/journal.ppat.1006786","article-title":"eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients","volume":"13","author":"Davis-Gardner","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.109167_bib22","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.cell.2015.11.056","article-title":"Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes","volume":"163","author":"de Taeye","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109167_bib23","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.20042510","article-title":"Antigenic conservation and immunogenicity of the HIV coreceptor binding site","volume":"201","author":"Decker","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.109167_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2017.10.002","article-title":"Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens","volume":"187","author":"DeFalco","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib25","doi-asserted-by":"crossref","first-page":"e1004767","DOI":"10.1371\/journal.ppat.1004767","article-title":"Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer","volume":"11","author":"Derking","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.109167_bib26","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.02779-15","article-title":"A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies","volume":"90","author":"Ding","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature13036","article-title":"Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies","volume":"509","author":"Doria-Rose","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109167_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01120-19","article-title":"Boosting with AIDSVAX B\/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency","volume":"94","author":"Easterhoff","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib29","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1128\/jvi.70.10.6547-6556.1996","article-title":"Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein","volume":"70","author":"Egan","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib30","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1128\/JVI.00171-11","article-title":"An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum","volume":"85","author":"Ferrari","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aal2144","article-title":"Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller","volume":"9","author":"Freund","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2021.109167_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature17677","article-title":"A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges","volume":"533","author":"Gautam","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109167_bib33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41591-018-0001-2","article-title":"A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection","volume":"24","author":"Gautam","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.109167_bib34","doi-asserted-by":"crossref","first-page":"36685","DOI":"10.1038\/srep36685","article-title":"Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240","volume":"6","author":"Gohain","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2021.109167_bib35","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1073\/pnas.0813392106","article-title":"Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection","volume":"106","author":"Guan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109167_bib36","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1073\/pnas.1217609110","article-title":"Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding","volume":"110","author":"Guan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109167_bib37","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","article-title":"Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data","volume":"31","author":"Gupta","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2021.109167_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nm.1974","article-title":"Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques","volume":"15","author":"Hessell","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.109167_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cell.2017.06.048","article-title":"Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In\u00a0Vivo","volume":"170","author":"Horwitz","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109167_bib40","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1074\/mcp.M900540-MCP200","article-title":"Post-translational modifications differentially affect IgG1 conformation and receptor binding","volume":"9","author":"Houde","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.celrep.2021.109167_bib41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109167_bib42","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2021.109167_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/vim.2011.0025","article-title":"NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients","volume":"24","author":"Johansson","year":"2011","journal-title":"Viral Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib44","doi-asserted-by":"crossref","first-page":"eaao4235","DOI":"10.1126\/scitranslmed.aao4235","article-title":"Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail","volume":"9","author":"Julg","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2021.109167_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.12688\/f1000research.2-103.v1","article-title":"Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors","volume":"2","author":"Kepler","year":"2013","journal-title":"F1000Res."},{"key":"10.1016\/j.celrep.2021.109167_bib46","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","article-title":"Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers","volume":"23","author":"Lambotte","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.celrep.2021.109167_bib47","doi-asserted-by":"crossref","first-page":"e74855","DOI":"10.1371\/journal.pone.0074855","article-title":"High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T\u00a0cell viral suppressive activity but not with B57 status in HIV-1 elite controllers","volume":"8","author":"Lambotte","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2021.109167_bib48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3389\/fimmu.2019.01025","article-title":"Knowns and unknowns of assaying antibody-dependent cell-mediated cytotoxicity against HIV-1","volume":"10","author":"Lewis","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib49","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1073\/pnas.1702173114","article-title":"Modulating IgG effector function by Fc glycan engineering","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109167_bib50","doi-asserted-by":"crossref","first-page":"eaat7796","DOI":"10.1126\/sciimmunol.aat7796","article-title":"Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement","volume":"3","author":"Lofano","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib51","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in\u00a0vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.109167_bib52","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in\u00a0vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.109167_bib53","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/QAD.0000000000000310","article-title":"Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design","volume":"28","author":"Madhavi","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.celrep.2021.109167_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00700-17","article-title":"HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV","volume":"91","author":"Madhavi","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib55","doi-asserted-by":"crossref","first-page":"12655","DOI":"10.1038\/s41598-017-12883-6","article-title":"Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity","volume":"7","author":"Mayr","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2021.109167_bib56","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1128\/JVI.02482-10","article-title":"Broadly cross-neutralizing antibodies in HIV-1 patients with undetectable viremia","volume":"85","author":"Medina-Ram\u00edrez","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib57","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","article-title":"Combination therapy with anti-HIV-1 antibodies maintains viral suppression","volume":"561","author":"Mendoza","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109167_bib58","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.80.5.2515-2528.2006","article-title":"Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1","volume":"80","author":"Moore","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib59","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"Mouquet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109167_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00634-17","article-title":"Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir","volume":"91","author":"Mujib","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1073\/pnas.97.1.343","article-title":"The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions","volume":"97","author":"Murakami","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109167_bib62","doi-asserted-by":"crossref","first-page":"19400","DOI":"10.1074\/jbc.M117.808352","article-title":"Time-course, negative-stain electron microscopy-based analysis for investigating protein-protein interactions at the single-molecule level","volume":"292","author":"Nogal","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2021.109167_bib63","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.celrep.2021.109167_bib64","doi-asserted-by":"crossref","first-page":"25269","DOI":"10.1073\/pnas.1910008116","article-title":"Single-molecule imaging of HIV-1 envelope glycoprotein dynamics and Gag lattice association exposes determinants responsible for virus incorporation","volume":"116","author":"Pezeshkian","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109167_bib65","doi-asserted-by":"crossref","first-page":"e00484-18","DOI":"10.1128\/JVI.00484-18","article-title":"Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses","volume":"92","author":"Pr\u00e9vost","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib66","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/JVI.03473-14","article-title":"A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene","volume":"89","author":"Pugach","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib67","doi-asserted-by":"crossref","first-page":"e00895-18","DOI":"10.1128\/JVI.00895-18","article-title":"Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs","volume":"92","author":"Ren","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib68","doi-asserted-by":"crossref","first-page":"e00358-18","DOI":"10.1128\/mBio.00358-18","article-title":"Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses","volume":"9","author":"Richard","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2021.109167_bib69","doi-asserted-by":"crossref","first-page":"e00264-17","DOI":"10.1128\/JVI.00264-17","article-title":"Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes","volume":"91","author":"Ringe","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib70","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1038\/ncomms11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"Robinson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.109167_bib71","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1128\/JVI.02213-14","article-title":"Enhanced potency of a broadly neutralizing HIV-1 antibody in\u00a0vitro improves protection against lentiviral infection in\u00a0vivo","volume":"88","author":"Rudicell","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib72","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/QAD.0000000000001716","article-title":"Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors","volume":"32","author":"Sadanand","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.celrep.2021.109167_bib73","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1128\/JVI.06547-11","article-title":"Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma","volume":"86","author":"Sajadi","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib74","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.cell.2018.03.061","article-title":"Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses","volume":"173","author":"Sajadi","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.109167_bib75","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20090378","article-title":"Genetic identity, biological phenotype, and evolutionary pathways of transmitted\/founder viruses in acute and early HIV-1 infection","volume":"206","author":"Salazar-Gonzalez","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.109167_bib76","doi-asserted-by":"crossref","first-page":"e1003618","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.109167_bib77","doi-asserted-by":"crossref","first-page":"e1005042","DOI":"10.1371\/journal.ppat.1005042","article-title":"Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques","volume":"11","author":"Santra","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.109167_bib78","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3389\/fimmu.2019.01296","article-title":"Conceptual approaches to modulating antibody effector functions and circulation half-life","volume":"10","author":"Saunders","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib79","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.109167_bib80","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"Scheid","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109167_bib81","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/mi.2016.12","article-title":"Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies","volume":"9","author":"Sips","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib82","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1073\/pnas.1415789111","article-title":"Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex","volume":"111","author":"Sok","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.109167_bib83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","article-title":"Automated molecular microscopy: the new Leginon system","volume":"151","author":"Suloway","year":"2005","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.celrep.2021.109167_bib84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2013.12.008","article-title":"High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination","volume":"151","author":"Tan","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib85","doi-asserted-by":"crossref","first-page":"e1005817","DOI":"10.1371\/journal.ppat.1005817","article-title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses","volume":"12","author":"Tay","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.109167_bib86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2016.03.002","article-title":"Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies","volume":"73","author":"Thomann","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib87","doi-asserted-by":"crossref","first-page":"e1007920","DOI":"10.1371\/journal.ppat.1007920","article-title":"Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics","volume":"15","author":"Torrents de la Pe\u00f1a","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.109167_bib88","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.4049\/jimmunol.145.10.3276","article-title":"Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies","volume":"145","author":"Tyler","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2021.109167_bib89","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/JVI.02868-14","article-title":"The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals","volume":"89","author":"Veillette","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib90","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1128\/JVI.01911-15","article-title":"Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity","volume":"89","author":"von Bredow","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib91","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/JVI.00347-16","article-title":"Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies","volume":"90","author":"von Bredow","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.109167_bib92","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.109167_bib93","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.109167_bib94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.aan8630","article-title":"Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques","volume":"358","author":"Xu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.109167_bib95","doi-asserted-by":"crossref","first-page":"e130153","DOI":"10.1172\/jci.insight.130153","article-title":"Predicting the broadly neutralizing antibody susceptibility of the HIV reservoir","volume":"4","author":"Yu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2021.109167_bib96","doi-asserted-by":"crossref","first-page":"e42166","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","volume":"7","author":"Zivanov","year":"2018","journal-title":"eLife"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472100509X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472100509X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:19:42Z","timestamp":1761909582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221112472100509X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":96,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S221112472100509X"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2021.109167","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2021.109167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"109167"}}